|Articles|August 8, 2011

Assisted Reproduction in the Treatment of Polycystic Ovary Syndrome

Newsletter

Get the latest clinical updates, case studies, and expert commentary in obstetric and gynecologic care. Sign up now to stay informed.

Subscribe Now!

Related Content

Routine second-trimester ultrasound screening accurately identifies vasa previa

ByContemporary OB/GYN Staff

December 16th 2025

Late-stage cervical cancer risk higher in older women

ByCeleste Krewson, Assistant Editor

December 16th 2025

FDA grants 510(k) clearance to Revi System against urgency urinary incontinence

ByCeleste Krewson, Assistant Editor

December 16th 2025

Transabdominal cerclage linked to lower preterm birth vs transvaginal cerclage

ByContemporary OB/GYN Staff

December 15th 2025

FDA approves expanded use of flibanserin for hypoactive sexual desire disorder in women

ByMorgan Ebert, Managing Editor

December 15th 2025

Latest CME

Multimedia

Expert Illustrations and Commentaries™: Visualizing Glucocorticoid Receptor Modulation in Platinum-Resistant Ovarian Cancer—Looking at Novel Pathways With an Eye Toward the Future of Treatment

Rachel N. Grisham, MD; Domenica Lorusso, MD, PhD

Multimedia

Community Practice Connections™: Optimizing Treatment Outcomes and Preserving Fertility in Premenopausal HR+ Breast Cancer

Rebecca Shatsky, MD; Kelly McCann, MD, PhD; Michelle L. Taylor, ANP-BC

Video

Show Me Your Care Plan!™ Insights for Oncology Nurses: Integrating Recent Developments to Improve Outcomes for Patients With Platinum-Resistant Ovarian Cancer

Ritu Salani, MD, MBA; Jill Alldredge, MD; Emely Alfaro, MS, RN, CNS, OCN

Audio

Show Me Your Care Plan!™ Insights for Oncology Nurses: Integrating Recent Developments to Improve Outcomes for Patients with Platinum-Resistant Ovarian Cancer

Ritu Salani, MD, MBA; Emely Alfaro, MS, RN, CNS, OCN; Jill Alldredge, MD

Video

Addressing Healthcare Inequities: Detecting and Managing the Uncommon – Hemophilia in Women

Danielle Nance, MD; Kimberley Youkhana, MD

Assisted Reproduction in the Treatment of Polycystic Ovary Syndrome

Newsletter

Related Content

Routine second-trimester ultrasound screening accurately identifies vasa previa

Late-stage cervical cancer risk higher in older women

FDA grants 510(k) clearance to Revi System against urgency urinary incontinence

Transabdominal cerclage linked to lower preterm birth vs transvaginal cerclage

FDA approves expanded use of flibanserin for hypoactive sexual desire disorder in women

Latest CME

Expert Illustrations and Commentaries™: Visualizing Glucocorticoid Receptor Modulation in Platinum-Resistant Ovarian Cancer—Looking at Novel Pathways With an Eye Toward the Future of Treatment

Community Practice Connections™: Optimizing Treatment Outcomes and Preserving Fertility in Premenopausal HR+ Breast Cancer

Show Me Your Care Plan!™ Insights for Oncology Nurses: Integrating Recent Developments to Improve Outcomes for Patients With Platinum-Resistant Ovarian Cancer

Show Me Your Care Plan!™ Insights for Oncology Nurses: Integrating Recent Developments to Improve Outcomes for Patients with Platinum-Resistant Ovarian Cancer

Addressing Healthcare Inequities: Detecting and Managing the Uncommon – Hemophilia in Women

Trending on Contemporary OB/GYN

FDA approves expanded use of flibanserin for hypoactive sexual desire disorder in women

FDA grants 510(k) clearance to Revi System against urgency urinary incontinence

Heavy menstrual bleeding linked to iron deficiency in adolescents

HMI-115 shows promising pain relief in endometriosis patients

Late-stage cervical cancer risk higher in older women